Cutaneous Manifestations in Patients with Polycystic Ovary Syndrome: Their Prevalence and Correlation with Hormonal and Metabolic Parameters

Abou Zaid, Samy E; Khedr, Nouran E; Gaafar, Sherif E; Gaber, Hend; Bondok, Maha E

doi:10.21608/zumj.2025.406916.4071

Cutaneous Manifestations in Patients with Polycystic Ovary Syndrome: Their Prevalence and Correlation with Hormonal and Metabolic Parameters

Document Type : Original Article

Authors

¹ Department of Dermatology Faculty of Medicine- University of Alexandria-Egypt

² Department of Dermatology- Faculty of Medicine- University of Alexandria-Egypt

³ Department of Obstetrics & Gynaecology- Faculty of Medicine- University of Alexandria-Egypt

⁴ Department of Internal Medicine-Endocrine Division- Faculty of Medicine-University of Alexandria- Alexandria-Egypt

10.21608/zumj.2025.406916.4071

Abstract

Background: We aimed to determine the prevalence of dermatologic manifestations among an Egyptian PCOS cohort and investigate their correlation with hormonal and metabolic changes.

Methods: A cross-sectional study was conducted on 53 patients with PCOS and 50 non-PCOS controls. Focused dermatologic examination was performed to assess hirsutism, acne, androgenic alopecia (AGA), and acanthosis nigricans (AN) using clinical scoring. Serum levels of total & free testosterone (TT, FT), dehydroepiandrosterone sulfate, prolactin, and homeostatic model assessment for insulin resistance (HOMA-IR) were estimated for patients with PCOS, along with pelvic ultrasound.

Results: Among our cohort, a significantly higher prevalence of hirsutism, AGA, acne & AN was observed in the PCOS group compared to the non-PCOS group, with prevalence rates of 49%, 45.3%, 39.6%, and 32% versus 10%, 12%, 16%, and 12%, respectively. In PCOS, hirsutism is associated with greater TT and FT. A significant positive correlation exists between the degree of hirsutism and TT & FT (P = 0.0001 and P = 0.0007, respectively). No significant difference in any of the measured parameters in PCOS patients with/without AGA. Patients with PCOS who had acne were younger (P = 0.001). Women with PCOS and AN had higher anthropometrics, HOMA-IR, and serum prolactin.

Conclusion: In this Egyptian cohort, cutaneous manifestations were common in PCOS, providing clinical clues. Androgen levels can influence the occurrence & degree of hirsutism in PCOS. Acne and AGA in PCOS can be caused by factors other than hyperandrogenism and insulin resistance. AN in PCOS is related to the metabolic derangement.

Keywords